Global Left Atrial Appendage Closure Market will Exhibit Positive Impact During 2020-2024 | Increasing Number of Product Approvals to Improve the Market Growth | Technavio

·5-min read

Technavio has been monitoring the left atrial appendage closure market, operating under the healthcare industry. The latest report on the left atrial appendage closure market, 2020-2024 estimates it to register an incremental growth of by USD 1.64 billion, at a CAGR of over 30% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here:

Technavio has announced its latest market research report titled Global Left Atrial Appendage Closure Market 2020-2024 (Graphic: Business Wire)

Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download Latest Free Sample Report on COVID-19 Analysis

The market is concentrated, and the degree of concentration will accelerate during the forecast period. Competitors have to focus on differentiating their product offerings with unique value propositions to strengthen their foothold in the market. Market vendors also have to leverage on the existing growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., and Occlutech International AB are among some of the major market participants.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Increasing number of product approvals has been instrumental in driving the growth of the market.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts

Left Atrial Appendage Closure Market 2020-2024: Segmentation

Left Atrial Appendage Closure Market is segmented as below:

  • Product

    • Epicardial LAA Closure Device

    • Endocardial LAA Closure Device

  • Geographic Landscape

    • Europe

    • North America

    • APAC

    • ROW

Based on geographic segmentation, over 40% of the market’s originated from Europe during the forecast period. In addition, epicardial LAA closure devices led the growth under the product segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the market size.

Left Atrial Appendage Closure Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The left atrial appendage closure market report covers the following areas:

  • Left Atrial Appendage Closure Market Size

  • Left Atrial Appendage Closure Market Trends

  • Left Atrial Appendage Closure Market Industry Analysis

This study identifies the potential long-term cost-effectiveness associated with use of LAA closure devices fueling market growth as one of the prime reasons driving the Left Atrial Appendage Closure Market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Left Atrial Appendage Closure Market 2020-2024: Key Highlights

  • CAGR of the market during the forecast period 2020-2024

  • Detailed information on factors that will assist left atrial appendage closure market growth during the next five years

  • Estimation of the left atrial appendage closure market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the left atrial appendage closure market

  • Analysis of the market’s competitive landscape and detailed information on vendors

  • Comprehensive details of factors that will challenge the growth of left atrial appendage closure market vendors

Table of Contents:

Executive Summary

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Product

  • Market segments

  • Comparison by Product

  • Epicardial LAA closure device - Market size and forecast 2019-2024

  • Endocardial LAA closure device - Market size and forecast 2019-2024

  • Market opportunity by Product

Market Segmentation by End-user

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • Europe - Market size and forecast 2019-2024

  • North America - Market size and forecast 2019-2024

  • APAC - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Volume drivers – Demand led growth

  • Volume drivers – External factors

  • Market challenges

  • Market trends

Vendor Landscape

  • Vendor landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Abbott Laboratories

  • Aegis Medical Group

  • Append Medical

  • AtriCure Inc.

  • Boston Scientific Corp.

  • Cardia Inc.

  • Carestream Health Inc.

  • Johnson & Johnson

  • Lifetech Scientific (Shenzhen) Co. Ltd.

  • Occlutech International AB


  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200